| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/28/2004 | EP1383749A1 Arylsulfonamides as antiviral agents |
| 01/28/2004 | EP1383747A1 Fused pyrimidines as antagonists of the corticotropin releasing factor (crf) |
| 01/28/2004 | EP1383744A1 Novel piperidine derivatives as modulators of chemokine receptor |
| 01/28/2004 | EP1383736A2 Peptide deformylase inhibitors |
| 01/28/2004 | EP1383729A1 Peptide deformylase inhibitors |
| 01/28/2004 | EP1383571A2 Microprojection array immunization patch and method |
| 01/28/2004 | EP1383563A2 Methods for the treatment of hiv and other viruses |
| 01/28/2004 | EP1383536A1 Use of herpesviruses, herpesvirus proteins and nucleic acids encoding the proteins to inhibit ccr5-tropic hiv-1 infection and replication |
| 01/28/2004 | EP1383535A2 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof |
| 01/28/2004 | EP1383534A2 Chlamydia vaccine composition |
| 01/28/2004 | EP1383528A2 Epitope sequences |
| 01/28/2004 | EP1383527A1 Methods and compositions for treating oral and esophageal lesions |
| 01/28/2004 | EP1383522A2 A medicament or a dressing containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of inflammatory skin conditions |
| 01/28/2004 | EP1383521A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use to induce apoptosis in cancerous tissue |
| 01/28/2004 | EP1383520A2 Medicament containing a metal such as silver, gold, platinum or palladium as an antimicrobial agent and their use in the treatment of diseases of the mucosa |
| 01/28/2004 | EP1383515A1 Activation of natural killer cells by adenosine a3 receptor agonists |
| 01/28/2004 | EP1383504A1 Sustained release drug delivery system containing codrugs |
| 01/28/2004 | EP1383499A2 Method of immunomodulation using thione-forming disulfides |
| 01/28/2004 | EP1383464A1 Nail compositions and methods of administering same |
| 01/28/2004 | EP1183237B1 Novel antioxidants, preparation methods and uses |
| 01/28/2004 | EP1143946B1 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis |
| 01/28/2004 | EP1089718B1 Sticking plaster for controlled release of natural interferon |
| 01/28/2004 | EP1082322B1 Oxazolidinone derivatives as antibiotic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/28/2004 | EP0957900B1 Compositions and methods for topical application of therapeutic agents |
| 01/28/2004 | EP0841927B1 Quinolones and their therapeutic use |
| 01/28/2004 | EP0636030B1 Pasteurella haemolytica type a-1 bacterin-toxoid vaccine |
| 01/28/2004 | CN1471583A Packaging of positive-strand RNA virus replicon particles |
| 01/28/2004 | CN1471580A Virus Particles with exogenous internal eitopes |
| 01/28/2004 | CN1471536A Chemokine receptor antagonsis and method of use thereof |
| 01/28/2004 | CN1471534A 桥(连)哌嗪衍生物 Bridge (even) piperazine derivatives |
| 01/28/2004 | CN1471522A Cholesterol lowering benzo [b] thiophenes and benzo[d] isothiazoles |
| 01/28/2004 | CN1471512A Gem-substituted ± ¢ ²3 integrin antagonists |
| 01/28/2004 | CN1471511A Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases |
| 01/28/2004 | CN1471509A 9-substituted minocycline compounds |
| 01/28/2004 | CN1471407A Multifunctional nano device platform |
| 01/28/2004 | CN1471401A Macrolide formulations for inhalation and methods of treatment of endobronchial infections |
| 01/28/2004 | CN1471399A Cephalosporin antibiotics and prodrugs thereof |
| 01/28/2004 | CN1471387A Oral dosage self-emulsifying formulations of pyranone proteinase inhibitors |
| 01/28/2004 | CN1470637A Hepatitis B virus core protein mutant and its use |
| 01/28/2004 | CN1470631A Microbe, microbial antivirus product and its use |
| 01/28/2004 | CN1470517A Composition containing crystalline and non-crystalline Aide-diester and use thereof |
| 01/28/2004 | CN1470286A Medicinal composition for immunopotentiation and its preparing method |
| 01/28/2004 | CN1470285A Polypeptide vaccine of anti Asiatic I virus of foot-and-mouth disease and its preparing method |
| 01/28/2004 | CN1470284A Use of vMIP and congeneric E protein ligand in pharmacy |
| 01/28/2004 | CN1470283A Method for preparing injecta of anti-hepatitis-B-virus transspecific factor |
| 01/28/2004 | CN1470282A Chinese medicine complex prescription for treating SARS and its preparnig method |
| 01/28/2004 | CN1470270A Chinese medicinal composition for preventing and treating non-typical pneumonia and its preparation method |
| 01/28/2004 | CN1470269A Lingjingchuandu compound preparation for treating non-typical pneumonia |
| 01/28/2004 | CN1470262A Shuanghuanglian preparation and its preparing method |
| 01/28/2004 | CN1470242A 4-de-dimethyltetracycline derivative use |
| 01/28/2004 | CN1470237A Use of chloroquine, hydroxychloroquine and 4-aminoquinazine derivatives in preparing medicine for antiretrovirus therapy |
| 01/28/2004 | CN1136222C 3-(2-oxo[1,3']bipyrrolidinyl-3-ylidenemethyl)-cephems |
| 01/28/2004 | CN1136216C Pyrone carboxy Lic acid derivative or lts salt and antibiotic with the same us effective component |
| 01/28/2004 | CN1136208C Intermediate for preparing 2-thiosubstituted carbapenems |
| 01/28/2004 | CN1136198C Novel benzyl pyrimidines |
| 01/28/2004 | CN1136187C 1-amino-alkylcyclohexane NMDA receptor antagonists |
| 01/28/2004 | CN1135989C Maternal immue secretions and their use in treatment and/or prophylaxis of conditions of human body |
| 01/28/2004 | CN1135986C Vaginal minocycline suppository |
| 01/28/2004 | CN1135985C Minocycline vaginal solution agent |
| 01/28/2004 | CN1135979C Application of sophocarpine in preparation of medicine for curing coxsackieverus B myocardits and its preparation method |
| 01/28/2004 | CN1135975C Vitamin E and esters therof for use in the topical treatment of mucosal pathologies |
| 01/27/2004 | US6683210 Human t-cell leukemia/lymphoma virus, human immunodeficiency virus, and lymphadenopathy associated virus treatment |
| 01/27/2004 | US6683201 Analine derivatives as OSC inhibitors |
| 01/27/2004 | US6683181 Mixing polystyrene-tosyl chloride resin with c2-12alkynol; reacting with amine to make chemical intermediate; herpes virus treatment |
| 01/27/2004 | US6683158 Alpha-subunit of the Mac-1 leukocyte adhesion receptor |
| 01/27/2004 | US6683097 Imidazole derivatives |
| 01/27/2004 | US6683093 Enzyme inhibitors; cardiovascular disorders; antiinflammatory agents; autoimmune disease |
| 01/27/2004 | US6683088 Sulfonamido ether substituted imidazoquinolines |
| 01/27/2004 | US6683079 Reverse transcriptase inhibitors |
| 01/27/2004 | US6683078 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 01/27/2004 | US6683077 2-Amino-benzoxazinones for the treatment of viral infections |
| 01/27/2004 | US6683068 For therapy of tetracycline compound-responsive states, such as bacterial infections and neoplasms |
| 01/27/2004 | US6683063 Lipopolysaccharide disorders |
| 01/27/2004 | US6683060 Chelating zinc with 1-(3,4-dihydroxy-5-(2-hydroxyethyl)-tetrahydrofuran-2-yl)pyrimidine -2,4(1h,3h)-dione; ovarian cancer |
| 01/27/2004 | US6683051 Pharmaceutical preparation containing a cyclopeptide and a chemotherapeutic agent or an angiogenesis inhibitor |
| 01/27/2004 | US6683029 Halopyrimidines |
| 01/27/2004 | US6682930 Triplex forming oligonucleotides and their use in anti-HBV |
| 01/27/2004 | US6682892 Screening for modulator of viral infectivity; obtain modulator, incubate with virus, monitor infectivity of virus |
| 01/27/2004 | US6682743 Genetically engineered virus for use in the propagation of preferential cells |
| 01/27/2004 | US6682742 Vector for integration of heterologous sequences into poxviral genomes |
| 01/27/2004 | CA2281927C Substituted benzimidazoles as non-nucleoside inhibitors of reverse transcriptase |
| 01/27/2004 | CA2261095C Compounds of the 3-aryl 2,4 dioxo oxazolidine family and use thereof in cosmetics and pharmaceuticals |
| 01/27/2004 | CA2254772C Liposomal antineoplaston therapies with markedly improved antineoplastic activity |
| 01/27/2004 | CA2214720C Arylsulfonylamino hydroxamic acid derivatives |
| 01/27/2004 | CA2140663C Compounds which inhibit hiv replication |
| 01/27/2004 | CA2109150C Heat sealable shrink laminate |
| 01/27/2004 | CA2069200C Crystalline acid addition salts of diastereomerically pure 1-(2,2-dimethylpropionyloxy)-ethyl-3-cephem-4-carboxylate |
| 01/27/2004 | CA2050569C Diphenyl compounds which inhibit arachidonic acid metabolism, and their use in pharmaceutical compositions |
| 01/25/2004 | CA2429287A1 Stable amorphous calcium pseudomonate and processes for the preparation thereof |
| 01/22/2004 | WO2004007769A1 Method of screening remedy for aids |
| 01/22/2004 | WO2004007747A2 Assays for assembly of ebola virus nucleocapsids |
| 01/22/2004 | WO2004007735A1 Methods of making viral particles having a modified cell binding activity and uses thereof |
| 01/22/2004 | WO2004007726A2 Brachyspira hyodysenteriae vaccine |
| 01/22/2004 | WO2004007709A2 Production of polyketides |
| 01/22/2004 | WO2004007548A1 Use of aspartic proteases in cosmetics and therapeutics |
| 01/22/2004 | WO2004007517A1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 01/22/2004 | WO2004007512A2 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/22/2004 | WO2004007505A1 Cephalosporins |
| 01/22/2004 | WO2004007497A1 Process for preparing 9-[4-acetoxy-3-(acetoxymethyl)but-1-yl]-2-aminopurine |
| 01/22/2004 | WO2004007491A1 Azolidinone-vinyl fused-benzene derivatives |